The JCA Subgroup should aim to select patients, clinical experts and other relevant experts who have the required expertise in the therapeutic area of the joint clinical assessment, from a European or international perspective. These experts should be consulted during the joint clinical assessment.
Recital 13, Regulation (EU) 2024/1381
In forcesince 23 May 2024